A Phase I Randomized, Double-Blind, Placebo-Controlled, Parallel Group Clinical Study of ICP-332 in Healthy Subjects

Clinical trial NCT05399030 · COMPLETED

Trial details

NCT number: NCT05399030
Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Subjects

Start date: 2021-08-14
Primary completion: 2022-01-30
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.